(Todd Ackerman, Houston Chronicle) The president of the University of Texas M.D. Anderson Cancer Center has been granted a limited waiver from the institution’s conflict-of-interest policy, allowing him to maintain financial ties with his three principal pharmaceutical companies. Dr. Kenneth Shine, the UT System’s vice chancellor for health affairs, revealed the decision in a letter …
Continue reading “WEDNESDAY NEWS LINKS:
Business As Usual for MD Anderson and The Cancer Prevention and Research Institute of Texas”
